Biodel Overview

  • Year Founded
  • 2003

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 39

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Financing Rounds
  • 12

  • Investments
  • 1

Biodel General Information

Description

Developer of endocrine disorders treatments based in Danbury, Connecticut. The company develops its product candidates by utilizing its proprietary VIAdel technology that allows to study the interaction between peptide hormones and small molecules.

Contact Information

Website
www.biodel.com
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 100 Saw Mill Road
  • Danbury, CT 06810
  • United States
Primary Industry
Drug Discovery
Other Industries
Drug Delivery
Acquirer
Corporate Office
  • 100 Saw Mill Road
  • Danbury, CT 06810
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Biodel Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Biodel‘s full profile, request access.

Request a free trial

Biodel Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of endocrine disorders treatments based in Danbury, Connecticut. The company develops its product candidates b
Drug Discovery
Danbury, CT
39 As of 2014

Leeds, United Kingdom
 

Cambridge, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Biodel Competitors (63)

One of Biodel’s 63 competitors is 4D pharma, a Corporation company based in Leeds, United Kingdom.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
4D pharma Corporation Leeds, United Kingdom
Vedanta Biosciences Venture Capital-Backed Cambridge, MA
Voyager Therapeutics Formerly VC-backed Lexington, MA
WaVe Life Sciences Formerly VC-backed Cambridge, MA
Maze Therapeutics Formerly VC-backed South San Francisco, CA
You’re viewing 5 of 63 competitors. Get the full list »

Biodel Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Biodel Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Biodel‘s full profile, request access.

Request a free trial

Biodel Acquisitions (1)

Biodel’s most recent deal was a Reverse Merger with Albireo. The deal was made on 03-Nov-2016.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Albireo 03-Nov-2016 Reverse Merger Drug Discovery
To view Biodel’s complete acquisitions history, request access »

Biodel Exits (1)

Biodel’s most recent exit was on 03-Nov-2016 from Albireo. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
Albireo 03-Nov-2016 Completed
To view Biodel’s complete exits history, request access »

Biodel FAQs

  • When was Biodel founded?

    Biodel was founded in 2003.

  • Where is Biodel headquartered?

    Biodel is headquartered in Danbury, CT.

  • What is the size of Biodel?

    Biodel has 39 total employees.

  • What industry is Biodel in?

    Biodel’s primary industry is Drug Discovery.

  • Is Biodel a private or public company?

    Biodel is a Private company.

  • What is Biodel’s current revenue?

    The current revenue for Biodel is .

  • How much funding has Biodel raised over time?

    Biodel has raised $223M.

  • Who are Biodel’s investors?

    Great Point Partners, Lancet Capital, Lincoln Park Capital, NMT Capital, and OrbiMed are 5 of 8 investors who have invested in Biodel.

  • Who are Biodel’s competitors?

    4D pharma, Vedanta Biosciences, Voyager Therapeutics, WaVe Life Sciences, and Maze Therapeutics are some of the 63 competitors of Biodel.

  • Who acquired Biodel?

    Biodel was acquired by Albireo.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process